Celcuity Wins FDA Approval for REVTORPYK in Breast Cancer
MINNEAPOLIS, Minn., July 14, 2026 Celcuity Inc. has achieved a major regulatory milestone after the U.S. Food and Drug...
AI in Healthcare
Advertisement
Autonomous Healthcare Creates New FDA Device Category with Syncron-E™
SANTA CLARA, Calif., July 14, 2026 Autonomous Healthcare has achieved a landmark regulatory milestone after the U.S. Food and...
Skyhawk Therapeutics Advances Global Phase 2/3 HD Trial
BOSTON, Mass. — July 14, 2026 Skyhawk Therapeutics, Inc. has announced a major expansion of its global pivotal Phase...
Caris Life Sciences Expands PTEN Testing for Prostate Cancer
IRVING, Texas — July 14, 2026 Caris Life Sciences has expanded its precision oncology portfolio with the launch of...
Channel Robotics Raises $4.6M for Endoscopic Robotics
SAN DIEGO, June 18, 2026 Channel Robotics, a pioneering medical technology company developing a novel AI-enabled handheld endoscopic robotic...
Advertisements
Akston’s AKS-699 Demonstrates One-Year Pruritus Control with Fewer Treatments
BEVERLY, Mass., June 16, 2026 Akston Biosciences Corporation has announced promising preclinical data demonstrating that its investigational immunotherapeutic AKS-699...
SonoClear Study Selected for EANS 2026 Oral Presentation
OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...
Nervonik Completes First Human Nerve Sensing Study
LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...
Alvotech Advances Key U.S. Biosimilars Toward FDA Review
REYKJAVIK, Iceland, June 4, 2026 Alvotech has announced the resubmission of U.S. Biologics License Applications (BLAs) for two important...
Philips and WellSpan Forge AI-Powered Healthcare Alliance
AMSTERDAM, Netherlands and YORK, Pa., June 4, 2026 Royal Philips and WellSpan Health have announced a landmark seven-year strategic...
Advertisement
